Ambrx to Present at the Baird and Morgan Stanley Global Healthcare Conferences

SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., Ambrx (or the “Company”) (NASDAQ: AMAM), today announced that Daniel J. O’Connor, Chief Executive Officer and President of Ambrx, will present a corporate overview and participate in one-on-one meetings at the Baird Global Healthcare Conference and the Morgan Stanley 21^st Annual Global Healthcare Conference, both being held in New York, NY. The presentations will focus on the status of Ambrx’s lead clinical candidates, ARX788 and ARX517.

Read more at globenewswire.com